Jump to content

Derek M. Yellon

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Russ Woodroofe (talk | contribs) at 07:18, 3 April 2022 (Undid revision 1080698766 by GSBHS (talk). rm unsourced and also WP:UNDUE high school). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Derek Miles Yellon is a South African-British researcher in the biomedical sciences, known for his work in cardiovascular medicine. He is a professor of molecular and cellular cardiology at University College London, and is director of the Hatter Cardiovascular Institute at University College London Hospitals and Medical School.

Education and career

Yellon was born in South Africa, to a British father and South African mother.[1][2] He had his early education at the University of Cape Town.[citation needed] He went on to a PhD in cardiovascular pharmacology from the University of Bath, which he received in 1978. His thesis title was Tolbutamide and the Ischaemic Heart.[3] In 1994, the University of Bath awarded him a DSc degree.[1]

After his PhD, Yellon worked for several years[quantify] in St. Thomas' Hospital in London.[1] He then worked as medical director for Lorex Pharmaceuticals, a small pharmaceutical company, from 1987 until it was acquired by a larger company in 1988.[1][4]

After leaving his job at the pharmaceutical company, Yellon was approached by University College London and the London Hospital about creating a department for cardiology research. He established the Hatter Cardiovascular Institute, a research centre focused on causes and treatment of cardiovascular disease, between 1990 and 1991 at University College London.[5][6] He was promoted to the title of professor by the same university in 1993.[7]

Yellon was instrumental in the founding of the Hatter Institute for Cardiovascular Research in Africa (independent of the London Hatter Institute) at the medical school of the University of Cape Town in 1996.[1][8] He continues to serve on its board.[9] In association with this development Yellon helped begin "At the Limits", a series of medical educational programmes.[10]

Awards and honors

References

  1. ^ a b c d e Shurlock, Barry (19 October 2010). "Pioneer in Cardiology: Derek Yellon". Circulation. American Heart Association. doi:10.1161/CIR.0b013e3181f8107b.
  2. ^ a b Lewis, Alison (16 December 2013). "Citation for DSc | Derek Miles Yellon" (PDF). University of Cape Town. Retrieved 9 August 2020.
  3. ^ Yellon, Derek Miles (1978). Tolbutamide and the Ischaemic Heart (PhD thesis). University of Bath. Retrieved 9 August 2020.
  4. ^ "Elections To The BSCR Committee 1990: The Candidates" (PDF). Quarterly Bulletin. 3 (3). British Society for Cardiovascular Research. 1990.
  5. ^ "Official page". Hatter Cardiovascular Institute. University College London. Retrieved 9 August 2020.
  6. ^ "About Us". Hatter Cardiovascular Institute. University College London. Retrieved 9 August 2020.
  7. ^ "Institutional Research Information Service". University College London. Retrieved 9 August 2020.
  8. ^ a b "Honorary Doctorates for Pioneering Entrepreneur, Cardiologist and Linguist". News. University of Cape Town. 9 December 2013. Retrieved 19 July 2017.
  9. ^ "Staff | Board". Hatter Institute for Cardiovascular Research in Africa. Retrieved 9 August 2020.
  10. ^ "Academic Founders". At The Limits. Retrieved 9 August 2020.
  11. ^ "Fellows of the ISHR". International Society for Heart Research. Retrieved 8 August 2020.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Derek_M._Yellon&oldid=1080754189"